A vaccine enters phase 2 trial in Wuhan. Volunteer recruitment for the vaccine began on Thursday. It is China’s first candidate that has entered clinical human testing phase.
The eldest volunteer is 84-year-old Wuhan resident who completed the vaccination on Monday morning.
The first phase of the vaccine clinical trial focused on its safety, while the second phase weighs more on its efficacy. .
Read more CNBC.